Dexcom Inc (NASDAQ: DXCM) is -24.55% lower on its value in year-to-date trading and has touched a low of $57.52 and a high of $117.19 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DXCM stock was last observed hovering at around $79.84 in the last trading session, with the day’s loss setting it -75.81%.
Currently trading at $4.03M, the stock is 3.95% and 9.38% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.2 million and changing 10197968% at the moment leaves the stock 13.79% off its SMA200. DXCM registered 12.60% gain for a year compared to 6-month gain of 16.36%. The firm has a 50-day simple moving average (SMA 50) of $80.0586 and a 200-day simple moving average (SMA200) of $76.9576.
The stock witnessed a 3.23% loss in the last 1 month and extending the period to 3 months gives it a 16.26%, and is 5.51% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.05% over the week and 2.48% over the month.
Dexcom Inc (DXCM) has around 10300 employees, a market worth around $34.34B and $4.15B in sales. Current P/E ratio is 65.74 and Fwd P/E is 34.44. Profit margin for the company is 12.90%. Distance from 52-week low is 52.24% and -25.28% from its 52-week high. The company has generated returns on investments over the last 12 months (14.78%).
The EPS is expected to grow by 23.67% this year.
Dexcom Inc (DXCM) Top Institutional Holders
1406.0 institutions hold shares in Dexcom Inc (DXCM), with institutional investors hold 97.64% of the company’s shares. The shares outstanding are 392.10M, and float is at 386.48M with Short Float at 2.69%. Institutions hold 97.23% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 46.51 million shares valued at $5.27 billion. The investor’s holdings represent 11.6516% of the DXCM Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 34.52 million shares valued at $3.91 billion to account for 8.6471 of the shares outstanding. The other top investors are STATE STREET CORP which holds 16.31 million shares representing 4.0853% and valued at over $1.85 billion, while BAILLIE GIFFORD & CO holds 3.8392 of the shares totaling 15.33 million with a market value of $1.74 billion.
Dexcom Inc (DXCM) Insider Activity
The most recent transaction is an insider sale by FOLETTA MARK G, the company’s Director. SEC filings show that FOLETTA MARK G sold 2,750 shares of the company’s common stock on Jun 16 ’25 at a price of $83.13 per share for a total of $0.23 million. Following the sale, the insider now owns 56621.0 shares.
Dexcom Inc disclosed in a document filed with the SEC on Jun 16 ’25 that Brown Michael Jon (EVP, Chief Legal Officer) sold a total of 500 shares of the company’s common stock. The trade occurred on Jun 16 ’25 and was made at $82.80 per share for $41400.0. Following the transaction, the insider now directly holds 95102.0 shares of the DXCM stock.
Still, SEC filings show that on Jun 16 ’25, AUGUSTINOS NICHOLAS (Director) disposed off 3,672 shares at an average price of $82.80 for $0.3 million. The insider now directly holds 33,411 shares of Dexcom Inc (DXCM).
